HARDY DIAGNOSTICS
FDA registration: United States Last updated 25 Oct 2026
- Devices
- 1,051
- Registries
- GUDIDFDA
- FDA recalls
- 202 ongoing
Catalogue
HardyFlask™ X19 Ref X19
HardyDisk™ Z9141 Ref Z9141
N/A K37 Ref K37
N/A L24 Ref L24
N/A C55 Ref C55
N/A C61 Ref C61
N/A 4000 Ref 4000
Na 295255 Ref 295255
N/A R97 Ref R97
N/A W75 Ref W75
Na 294371 Ref 294371
N/A J67 Ref J67
N/A G12 Ref G12
N/A A66 Ref A66
N/A Z54 Ref Z54
N/A Q06 Ref Q06
N/A W58 Ref W58
N/A Y22 Ref Y22
N/A G01 Ref G01
N/A Y119 Ref Y119
N/A Y311 Ref Y311
HardyFlask™ X25 Ref X25
SporAmpule® BST100 Ref BST100
Na 294838 Ref 294838
N/A A134 Ref A134
N/A G223 Ref G223
N/A Y24 Ref Y24
N/A L80 Ref L80
Na 294470 Ref 294470
N/A Z173 Ref Z173
AnaeroGRO AG701 Ref AG701
GlabrataQuick™ Z298 Ref Z298
HardyFlask™ X30 Ref X30
N/A Z18 Ref Z18
N/A 3001 Ref 3001
Na 294098 Ref 294098
Na 290526 Ref 290526
N/A R21 Ref R21
N/A J85 Ref J85
Na 295149 Ref 295149
N/A G251 Ref G251
N/A J92 Ref J92
N/A L37 Ref L37
N/A A81 Ref A81
N/A L48 Ref L48
N/A R87 Ref R87
Na 295040 Ref 295040
N/A Y53 Ref Y53
N/A Q04 Ref Q04
N/A K147 Ref K147
Showing 851-900 of 1,051
FDA recalls
2026
- 8 Jun 2026 Z-2887-2026 Class II Ongoing Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy, potentially resulting in delayed appropriate treatment, prolonged infection, or worsening clinical outcome.
2025
- 6 May 2025 Z-2041-2025 Class II Ongoing Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.
2021
- 16 Apr 2021 Z-1835-2021 Class II Terminated Instruments were assembled and serviced using a defective lot of tubing, which is part of the pump mechanism within the unit.
2020
- 21 Dec 2020 Z-0919-2021 Class II Terminated Complaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited.
- 23 Oct 2020 Z-0655-2021 Class II Terminated There is a potential for contamination within Viral Transport Media. Use of contaminated Viral Transport Media for the transport of patient specimen may compromise the detection of COVID-19 by the final device used for testing.
- 6 Oct 2020 Z-0441-2021 Class III Terminated Streptococcus culture medium contains an incorrect expiration date. The culture medium outer box labeling contains an expiration date of 2021-11-10 instead of the correct expiration date of 2020-11-10
2019
- 14 Nov 2019 Z-2298-2020 Class II Terminated False Positive results due to the MSSA (methicillin-susceptible) strain Staphylococcus aureus (ATCC 29213) breakthrough when this strain should have been inhibited.
2016
- 24 May 2016 Z-2146-2016 Class II Terminated Discrepant culture and gram stain results, which could potentially lead to misdiagnosis or improper treatment of a patient.
- 21 Mar 2016 Z-1571-2016 Class II Terminated Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration.
2015
- 18 Nov 2015 Z-0470-2016 Class II Terminated The firm is recalling FB Broth Cat. no. K31, Lot no. 15231 because of potential Burkholderia fungorum contamination.
Show all 20 recalls
2015
- 9 Jul 2015 Z-2463-2015 Class II Terminated Hardy Diagnostics is recalling HardyCHROm MRSA due to a report of the potential for breakthrough of the methicillin-sensitive Staphylococcus aureus (MSSA) QC strain, ATCC 29213 on the identified lot.
- 26 Jun 2015 Z-2273-2015 Class II Terminated Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.
- 26 Jun 2015 Z-2274-2015 Class II Terminated Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.
- 26 Jun 2015 Z-2275-2015 Class II Terminated Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.
- 26 Jun 2015 Z-2276-2015 Class II Terminated Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.
- 26 Jun 2015 Z-2277-2015 Class II Terminated Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.
- 26 Jun 2015 Z-2278-2015 Class II Terminated Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.
- 26 Jun 2015 Z-2279-2015 Class II Terminated Hardy Diagnostics is recalling MacConkey Agar with Ciprofloxacin, Brain Heart Infusion Broth with Ciprofloxacin 1 ug, MDR Acinetobacter, BEA with Azide and Vancomycin, BEA Agar with Vancomycin, Gentamicin, and Amphotericin B, BEA Broth with Vancomycin, and VRE Broth due to lack of 510(k) clearance.
- 24 Jun 2015 Z-2192-2015 Class II Terminated Hardy Diagnostics is recalling HardyCHROM VRE Agar due to lack of 510(k) clearance.
- 4 Mar 2015 Z-1444-2015 Class II Terminated The firm is recalling HardyCHROM SS, Cat. no. G327 Lot no. 15037 due to a report of possible lack of color development in Shigella organisms in the referenced lot.
Information
- FDA registration
- United States
- Address
- 1430 WEST MCCOY LN., Orcutt, CA, 93455
- Website
- hardydiagnostics.com
- [email protected]
- Phone
- 800-266-2222
- FDA FEI number
- 2022807
- DUNS number
- 039981550